US Patent Issued to NODEN PHARMA DESIGNATED ACTIVITY on Dec. 30 for "Pharmaceutical compositions and methods of using the same" (Pennsylvania Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,256, issued on Dec. 30, was assigned to NODEN PHARMA DESIGNATED ACTIVITY COMPANY (Dublin).

"Pharmaceutical compositions and methods of using the same" was invented by Jeffrey M. Moshal (Allentown, Pa.) and Michael Libman (Allentown, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described."

The patent was filed on June 29, 2023, under Application No. 18/344,081.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&...